Microwave Ablation Combined with Flt3L Provokes Tumor‐Specific Memory CD8+ T Cells‐Mediated Antitumor Immunity in Response to PD‐1 Blockade

Abstract For medically inoperable non‐small cell lung cancer, microwave ablation (MWA) represents a super minimally invasive alternative treatment. However, tumor recurrence remains a concern. Here, it is demonstrated that the combination of MWA with Flt3L significantly inhibits tumor recurrence by...

Full description

Saved in:
Bibliographic Details
Main Authors: Meixiang Wang, Jing Sang, Fengkuo Xu, Shulong Wang, Peng Liu, Ji Ma, Zhengtao Chen, Qi Xie, Zhigang Wei, Xin Ye
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:Advanced Science
Subjects:
Online Access:https://doi.org/10.1002/advs.202413181
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832582753822965760
author Meixiang Wang
Jing Sang
Fengkuo Xu
Shulong Wang
Peng Liu
Ji Ma
Zhengtao Chen
Qi Xie
Zhigang Wei
Xin Ye
author_facet Meixiang Wang
Jing Sang
Fengkuo Xu
Shulong Wang
Peng Liu
Ji Ma
Zhengtao Chen
Qi Xie
Zhigang Wei
Xin Ye
author_sort Meixiang Wang
collection DOAJ
description Abstract For medically inoperable non‐small cell lung cancer, microwave ablation (MWA) represents a super minimally invasive alternative treatment. However, tumor recurrence remains a concern. Here, it is demonstrated that the combination of MWA with Flt3L significantly inhibits tumor recurrence by CD8+ central memory T (TCM)‐like cell‐dependent antitumor immune responses within the tumor‐draining lymph nodes (TdLN). TdLN‐TCM‐like cells encompassed both tumor‐specific memory T (TTSM) and progenitor‐exhausted T (TPEX) cells. The expansion of these cells markedly altered the differentiation of exhausted T cells within the tumor microenvironment (TME). TPEX predominantly differentiated into transitory effector‐like exhausted T cells (TEX‐int). The expansion of TTSM cells elicited by the combined therapy was reliant on conventional dendritic cells (cDCs) and was likely specifically dependent on the migratory cDC1s (Mig cDC1s) within the TdLN. The upregulation of ICOSL on migratory cDC1s was pivotal in initiating TTSM‐like cell‐mediated antitumor responses. Slc38a2 may be a critical gene responsible for the upregulation of ICOSL in Mig cDC1s following combined treatment. Finally, the combined treatment significantly enhanced the antitumor efficacy of immunotherapy based on PD‐1 blockade. The research thereby afforded a novel strategic approach to forestall tumor recurrence after MWA therapy, while also providing the foundational proof‐of‐concept for impending clinical investigations.
format Article
id doaj-art-7565294e4a0d42419365d7bd361d58eb
institution Kabale University
issn 2198-3844
language English
publishDate 2025-01-01
publisher Wiley
record_format Article
series Advanced Science
spelling doaj-art-7565294e4a0d42419365d7bd361d58eb2025-01-29T09:50:19ZengWileyAdvanced Science2198-38442025-01-01124n/an/a10.1002/advs.202413181Microwave Ablation Combined with Flt3L Provokes Tumor‐Specific Memory CD8+ T Cells‐Mediated Antitumor Immunity in Response to PD‐1 BlockadeMeixiang Wang0Jing Sang1Fengkuo Xu2Shulong Wang3Peng Liu4Ji Ma5Zhengtao Chen6Qi Xie7Zhigang Wei8Xin Ye9Department of Oncology The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital Shandong Provincial Lab for Clinical Immunology Translational Medicine in Universities Shandong Lung Cancer Institute 16766 Jingshi Road Jinan 250014 P. R. ChinaDepartment of Oncology The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital Shandong Provincial Lab for Clinical Immunology Translational Medicine in Universities Shandong Lung Cancer Institute 16766 Jingshi Road Jinan 250014 P. R. ChinaDepartment of Oncology The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital Shandong Provincial Lab for Clinical Immunology Translational Medicine in Universities Shandong Lung Cancer Institute 16766 Jingshi Road Jinan 250014 P. R. ChinaShandong Academy of Preventive Medicine Shandong Center for Disease Control and Prevention 16992 Jingshi Road Jinan 250014 P. R. ChinaDepartment of Oncology The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital Shandong Provincial Lab for Clinical Immunology Translational Medicine in Universities Shandong Lung Cancer Institute 16766 Jingshi Road Jinan 250014 P. R. ChinaDepartment of Oncology The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital Shandong Provincial Lab for Clinical Immunology Translational Medicine in Universities Shandong Lung Cancer Institute 16766 Jingshi Road Jinan 250014 P. R. ChinaSchool of Laboratory Animal & Shandong Laboratory Animal Center Shandong First Medical University & Shandong Academy of Medical Sciences 6699 Qingdao Road Jinan 250014 P. R. ChinaDepartment of Oncology The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital Shandong Provincial Lab for Clinical Immunology Translational Medicine in Universities Shandong Lung Cancer Institute 16766 Jingshi Road Jinan 250014 P. R. ChinaDepartment of Oncology The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital Shandong Provincial Lab for Clinical Immunology Translational Medicine in Universities Shandong Lung Cancer Institute 16766 Jingshi Road Jinan 250014 P. R. ChinaDepartment of Oncology The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital Shandong Provincial Lab for Clinical Immunology Translational Medicine in Universities Shandong Lung Cancer Institute 16766 Jingshi Road Jinan 250014 P. R. ChinaAbstract For medically inoperable non‐small cell lung cancer, microwave ablation (MWA) represents a super minimally invasive alternative treatment. However, tumor recurrence remains a concern. Here, it is demonstrated that the combination of MWA with Flt3L significantly inhibits tumor recurrence by CD8+ central memory T (TCM)‐like cell‐dependent antitumor immune responses within the tumor‐draining lymph nodes (TdLN). TdLN‐TCM‐like cells encompassed both tumor‐specific memory T (TTSM) and progenitor‐exhausted T (TPEX) cells. The expansion of these cells markedly altered the differentiation of exhausted T cells within the tumor microenvironment (TME). TPEX predominantly differentiated into transitory effector‐like exhausted T cells (TEX‐int). The expansion of TTSM cells elicited by the combined therapy was reliant on conventional dendritic cells (cDCs) and was likely specifically dependent on the migratory cDC1s (Mig cDC1s) within the TdLN. The upregulation of ICOSL on migratory cDC1s was pivotal in initiating TTSM‐like cell‐mediated antitumor responses. Slc38a2 may be a critical gene responsible for the upregulation of ICOSL in Mig cDC1s following combined treatment. Finally, the combined treatment significantly enhanced the antitumor efficacy of immunotherapy based on PD‐1 blockade. The research thereby afforded a novel strategic approach to forestall tumor recurrence after MWA therapy, while also providing the foundational proof‐of‐concept for impending clinical investigations.https://doi.org/10.1002/advs.202413181dendritic cellsICOS‐ICOSL axismicrowave ablationnon‐small cell lung cancertumor‐specific memory CD8+ T cells
spellingShingle Meixiang Wang
Jing Sang
Fengkuo Xu
Shulong Wang
Peng Liu
Ji Ma
Zhengtao Chen
Qi Xie
Zhigang Wei
Xin Ye
Microwave Ablation Combined with Flt3L Provokes Tumor‐Specific Memory CD8+ T Cells‐Mediated Antitumor Immunity in Response to PD‐1 Blockade
Advanced Science
dendritic cells
ICOS‐ICOSL axis
microwave ablation
non‐small cell lung cancer
tumor‐specific memory CD8+ T cells
title Microwave Ablation Combined with Flt3L Provokes Tumor‐Specific Memory CD8+ T Cells‐Mediated Antitumor Immunity in Response to PD‐1 Blockade
title_full Microwave Ablation Combined with Flt3L Provokes Tumor‐Specific Memory CD8+ T Cells‐Mediated Antitumor Immunity in Response to PD‐1 Blockade
title_fullStr Microwave Ablation Combined with Flt3L Provokes Tumor‐Specific Memory CD8+ T Cells‐Mediated Antitumor Immunity in Response to PD‐1 Blockade
title_full_unstemmed Microwave Ablation Combined with Flt3L Provokes Tumor‐Specific Memory CD8+ T Cells‐Mediated Antitumor Immunity in Response to PD‐1 Blockade
title_short Microwave Ablation Combined with Flt3L Provokes Tumor‐Specific Memory CD8+ T Cells‐Mediated Antitumor Immunity in Response to PD‐1 Blockade
title_sort microwave ablation combined with flt3l provokes tumor specific memory cd8 t cells mediated antitumor immunity in response to pd 1 blockade
topic dendritic cells
ICOS‐ICOSL axis
microwave ablation
non‐small cell lung cancer
tumor‐specific memory CD8+ T cells
url https://doi.org/10.1002/advs.202413181
work_keys_str_mv AT meixiangwang microwaveablationcombinedwithflt3lprovokestumorspecificmemorycd8tcellsmediatedantitumorimmunityinresponsetopd1blockade
AT jingsang microwaveablationcombinedwithflt3lprovokestumorspecificmemorycd8tcellsmediatedantitumorimmunityinresponsetopd1blockade
AT fengkuoxu microwaveablationcombinedwithflt3lprovokestumorspecificmemorycd8tcellsmediatedantitumorimmunityinresponsetopd1blockade
AT shulongwang microwaveablationcombinedwithflt3lprovokestumorspecificmemorycd8tcellsmediatedantitumorimmunityinresponsetopd1blockade
AT pengliu microwaveablationcombinedwithflt3lprovokestumorspecificmemorycd8tcellsmediatedantitumorimmunityinresponsetopd1blockade
AT jima microwaveablationcombinedwithflt3lprovokestumorspecificmemorycd8tcellsmediatedantitumorimmunityinresponsetopd1blockade
AT zhengtaochen microwaveablationcombinedwithflt3lprovokestumorspecificmemorycd8tcellsmediatedantitumorimmunityinresponsetopd1blockade
AT qixie microwaveablationcombinedwithflt3lprovokestumorspecificmemorycd8tcellsmediatedantitumorimmunityinresponsetopd1blockade
AT zhigangwei microwaveablationcombinedwithflt3lprovokestumorspecificmemorycd8tcellsmediatedantitumorimmunityinresponsetopd1blockade
AT xinye microwaveablationcombinedwithflt3lprovokestumorspecificmemorycd8tcellsmediatedantitumorimmunityinresponsetopd1blockade